Psoriasis is a chronic inflammatory skin disease associated with epidermal keratinocyte
hyperplasia and epidermal immune cell over-activation. Compositions of both local skin and …

Abstract Background Psoriasis impacts 1–3% of the world's population and is characterized
by hyper-proliferation of keratinocytes and increased inflammation. At the molecular level …

Psoriasis is a multifactorial immune-mediated disease. The highly effective and eligible
treatment for psoriasis is limited, for its specific pathogenesis is incompletely elucidated …

Psoriasis (PsO) and psoriatic arthritis (PsA) are chronic immune-mediated inflammatory
diseases of multifactorial etiology. In addition to genetic and environmental factors, evidence …

The skin microbiome is made of various microorganisms, most of which have the function of
protecting individuals from harmful pathogens, and they are involved in innate and adaptive …

With advancement in human microbiome research, an increasing number of scientific
evidences have endorsed the key role of both gut and skin microbiota in the pathogenesis of …

Psoriasis affects the health of myriad populations around the world. The pathogenesis is
multifactorial, and the exact driving factor remains unclear. This condition arises from the …

Evidence has shown that gut microbiome plays a role in modulating the development of
diseases beyond the gastrointestinal tract, including skin disorders such as psoriasis. The …

Psoriasis is a chronic inflammatory skin disease with autoimmune pathogenic characteristics
and is caused by chronic inflammation, which results in uncontrolled keratinocyte growth …

Background: Recent advances have highlighted the crucial role of microbiota in the
pathophysiology of chronic inflammatory diseases as well as its impact on the efficacy of …